Kathleen A. Brady
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathleen A. Brady has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Danica Kuncio
Division of Disease Control–Hepatitis, Philadelphia Department of Public Health , Philadelphia, Pennsylvania
2 shared publications - Melissa M. Kim
Division of HIV Health, Philadelphia Department of Public Health , Philadelphia, Pennsylvania
2 shared publications - Tanner Nassau
Division of HIV Health, Philadelphia Department of Public Health , Philadelphia, Pennsylvania
2 shared publications Alagie Jatta
1 shared publication- Amy I. Zlot
HIV/STD/TB Section of the Public Health, Division of the Oregon Health Authority, Portland, OR
1 shared publication Anna Sweeney
The University of Pennsylvania School of Nursing, Philadelphia, PA, USA
1 shared publication
Latest Publications
- Open Access
- 12 August 2026
- Published by Elsevier in AJPM Focus
- Vol. 5 (6)
Increases in Overdose Deaths Among People With HIV Across 14 U.S. Jurisdictions, 2014–2023
- 12 August 2026
- Published by Elsevier in AJPM Focus
- Vol. 5 (6)
Open AccessIncreases in Overdose Deaths Among People With HIV Across 14 U.S. Jurisdictions, 2014–2023
- Open Access
- 12 March 2026
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (10) , 1-13
Women in the HIV Care Continuum: Assessing Re-linking Women to Care and Maintaining Viral Suppression Postpartum in Philadelphia from 2012 to 2023
The purpose of this study was to describe the HIV care continuum postpartum in a cohort of postpartum women with HIV (WWH) in Philadelphia, and assess the impact of the City’s perinatal case management (PCM) program on engagement in the HIV care continuum. A cohort of 937 mothers who gave birth between 1/1/2012 and 12/31/2023 and who lived, gave birth, or received perinatal and pediatric care in Philadelphia, PA were enrolled. Using public health surveillance data, the impact of PCM use on engagement in care at 90 days postpartum, retention in care at 1-year postpartum, and viral suppression at 1-year postpartum was assessed using logistic regression with robust standard errors. Overall, 51.1%, 65.4%, and 42.0% of the population was engaged in care at 90 days, and retained in care and virally suppressed at 1-year, respectively. A larger percentage of PCM users than non-users were engaged in care at 90 days (56.4% versus 43.9%) and retained in care (73.2% versus 59.2%) and virally suppressed (48.2% versus 37.1%) at 1 year. After controlling for confounders, PCM use was significantly associated with increased engagement in care at 90 days (aOR = 1.403 [1.030–1.913]), retention in care at 1 year (aOR = 1.576 [1.163–2.136]), and viral suppression at 1 year (aOR = 1.412 [1.060–1.881]). Philadelphia’s PCM program is effective in improving engagement in the HIV care continuum during the postpartum period. Other US cities, particularly those with high HIV prevalence, should consider adopting a similar city-funded PCM program for pregnant and postpartum WWH.
- 12 March 2026
- Published by Springer Nature in AIDS and Behavior
- Vol. 30 (10) , 1-13
Open AccessWomen in the HIV Care Continuum: Assessing Re-linking Women to Care and Maintaining Viral Suppression Postpartum in Philadelphia from 2012 to 2023
The purpose of this study was to describe the HIV care continuum postpartum in a cohort of postpartum women with HIV (WWH) in Philadelphia, and assess the impact of the City’s perinatal case management (PCM) program on engagement in the HIV care continuum. A cohort of 937 mothers who gave birth between 1/1/2012 and 12/31/2023 and who lived, gave birth, or received perinatal and pediatric care in Philadelphia, PA were enrolled. Using public health surveillance data, the impact of PCM use on engagement in care at 90 days postpartum, retention in care at 1-year postpartum, and viral suppression at 1-year postpartum was assessed using logistic regression with robust standard errors. Overall, 51.1%, 65.4%, and 42.0% of the population was engaged in care at 90 days, and retained in care and virally suppressed at 1-year, respectively. A larger percentage of PCM users than non-users were engaged in care at 90 days (56.4% versus 43.9%) and retained in care (73.2% versus 59.2%) and virally suppressed (48.2% versus 37.1%) at 1 year. After controlling for confounders, PCM use was significantly associated with increased engagement in care at 90 days (aOR = 1.403 [1.030–1.913]), retention in care at 1 year (aOR = 1.576 [1.163–2.136]), and viral suppression at 1 year (aOR = 1.412 [1.060–1.881]). Philadelphia’s PCM program is effective in improving engagement in the HIV care continuum during the postpartum period. Other US cities, particularly those with high HIV prevalence, should consider adopting a similar city-funded PCM program for pregnant and postpartum WWH.
- Open Access
- 2 February 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Frequent Participation in Ryan White Services Improves Time to Human Immunodeficiency Virus (HIV) Viral Suppression Among People With HIV Monoinfection and People With Hepatitis C Virus (HCV) Coinfection in Philadelphia
Background: Hepatitis C virus (HCV) coinfection is associated with poor health outcomes for persons with human immunodeficiency virus (HIV). Although higher HIV viral suppression rates have been reported among people with HIV who participate in Ryan White services, studies have not assessed effects on HCV coinfection. Methods: We used Philadelphia's routine HIV and hepatitis surveillance data to identify new HIV diagnoses during November 2018–October 2021 in a retrospective cohort analysis. We plotted Kaplan-Meier curves and performed Cox regressions to understand effects of HCV coinfection and receipt of Ryan White support services on time to reach HIV viral suppression, adjusting for linkage to HIV care, retention in HIV care, race and ethnicity, gender, age at time of HIV diagnosis, and injection drug use history. Results: Kaplan–Meier plots revealed that median time to HIV viral suppression was shorter among persons with HIV monoinfection, compared with HIV and HCV coinfection (80 days vs 235 days; P < .001). When adjusted for covariates, persons with HCV coinfection remained less likely to reach HIV viral suppression than persons without HCV coinfection for each day of follow-up (hazard ratio, 0.53 [95% confidence interval {CI}, .39–.72]). Compared with persons who received no support services, persons who received ≥1 service weekly and persons who received ≥2 services weekly were 60% (95% CI, 27%–101%) and 117% (95% CI, 36%– 223%) more likely to achieve viral suppression, respectively, for each day of follow-up. Conclusions: Addressing social determinants of health through federally sponsored Ryan White services can improve health for persons with HIV monoinfection and HCV coinfection.
- 2 February 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Open AccessFrequent Participation in Ryan White Services Improves Time to Human Immunodeficiency Virus (HIV) Viral Suppression Among People With HIV Monoinfection and People With Hepatitis C Virus (HCV) Coinfection in Philadelphia
Background: Hepatitis C virus (HCV) coinfection is associated with poor health outcomes for persons with human immunodeficiency virus (HIV). Although higher HIV viral suppression rates have been reported among people with HIV who participate in Ryan White services, studies have not assessed effects on HCV coinfection. Methods: We used Philadelphia's routine HIV and hepatitis surveillance data to identify new HIV diagnoses during November 2018–October 2021 in a retrospective cohort analysis. We plotted Kaplan-Meier curves and performed Cox regressions to understand effects of HCV coinfection and receipt of Ryan White support services on time to reach HIV viral suppression, adjusting for linkage to HIV care, retention in HIV care, race and ethnicity, gender, age at time of HIV diagnosis, and injection drug use history. Results: Kaplan–Meier plots revealed that median time to HIV viral suppression was shorter among persons with HIV monoinfection, compared with HIV and HCV coinfection (80 days vs 235 days; P < .001). When adjusted for covariates, persons with HCV coinfection remained less likely to reach HIV viral suppression than persons without HCV coinfection for each day of follow-up (hazard ratio, 0.53 [95% confidence interval {CI}, .39–.72]). Compared with persons who received no support services, persons who received ≥1 service weekly and persons who received ≥2 services weekly were 60% (95% CI, 27%–101%) and 117% (95% CI, 36%– 223%) more likely to achieve viral suppression, respectively, for each day of follow-up. Conclusions: Addressing social determinants of health through federally sponsored Ryan White services can improve health for persons with HIV monoinfection and HCV coinfection.
- Open Access
- 19 June 2025
- Published by SAGE Publications in Health Promotion Practice
- Vol. 27 (3) , 564-575
Facilitators and Barriers to Equitable Implementation of Telehealth PrEP Delivery: A Qualitative Descriptive Study of Program Staff and Stakeholders
Expanding access to pre-exposure prophylaxis (PrEP) is crucial for ending the HIV epidemic in the United States and reducing disparities in HIV incidence among marginalized populations. Telehealth models for the delivery of PrEP have the potential to improve access, acceptability, and adherence. In 2022, Philadelphia established the Philadelphia TelePrEP Program to deliver HIV prevention services through telehealth. This qualitative descriptive study aims to identify implementation determinants for telehealth PrEP services in Philadelphia. We completed nine in-depth interviews with staff at the Philadelphia TelePrEP Program (n = 5) and external stakeholders in the HIV prevention workforce (n = 4) using a semi-structured interview guide based on the Consolidated Framework for Implementation Research (CFIR). Thematic analysis was used to identify key facilitators and barriers to implementation. Interviews revealed that telePrEP improved convenience and flexibility in accessing PrEP, but online marketing may exclude certain populations with limited digital presence. Dedicated patient navigators and ongoing staff training were key facilitators, whereas limited provider capacity was a challenge. Sustainable funding through grants and 340B revenue enabled the Philadelphia TelePrEP Program to serve uninsured patients. The digital divide, lack of PrEP awareness, and competition from commercial telePrEP providers were identified as potential barriers to engaging priority populations. TelePrEP has the potential to expand the availability of PrEP services and reach communities that currently face barriers to access. However, overcoming key structural and social barriers around public awareness, technology access, and organizational capacity will be critical for successful implementation.
- 19 June 2025
- Published by SAGE Publications in Health Promotion Practice
- Vol. 27 (3) , 564-575
Open AccessFacilitators and Barriers to Equitable Implementation of Telehealth PrEP Delivery: A Qualitative Descriptive Study of Program Staff and Stakeholders
Expanding access to pre-exposure prophylaxis (PrEP) is crucial for ending the HIV epidemic in the United States and reducing disparities in HIV incidence among marginalized populations. Telehealth models for the delivery of PrEP have the potential to improve access, acceptability, and adherence. In 2022, Philadelphia established the Philadelphia TelePrEP Program to deliver HIV prevention services through telehealth. This qualitative descriptive study aims to identify implementation determinants for telehealth PrEP services in Philadelphia. We completed nine in-depth interviews with staff at the Philadelphia TelePrEP Program (n = 5) and external stakeholders in the HIV prevention workforce (n = 4) using a semi-structured interview guide based on the Consolidated Framework for Implementation Research (CFIR). Thematic analysis was used to identify key facilitators and barriers to implementation. Interviews revealed that telePrEP improved convenience and flexibility in accessing PrEP, but online marketing may exclude certain populations with limited digital presence. Dedicated patient navigators and ongoing staff training were key facilitators, whereas limited provider capacity was a challenge. Sustainable funding through grants and 340B revenue enabled the Philadelphia TelePrEP Program to serve uninsured patients. The digital divide, lack of PrEP awareness, and competition from commercial telePrEP providers were identified as potential barriers to engaging priority populations. TelePrEP has the potential to expand the availability of PrEP services and reach communities that currently face barriers to access. However, overcoming key structural and social barriers around public awareness, technology access, and organizational capacity will be critical for successful implementation.